Intellectual Property Management

Domain Overview

Intellectual property management encompasses the strategic acquisition, prosecution, maintenance, enforcement, licensing, and valuation of patents, trademarks, trade secrets, and copyrights within an enterprise portfolio. The U.S. patent system, fundamentally reshaped by the Leahy-Smith America Invents Act (AIA) of 2011, operates under a first-inventor-to-file regime (effective March 16, 2013) codified in revised 35 USC § 102. This shift eliminated interference proceedings in favor of derivation proceedings, broadened prior art definitions to include foreign public use and on-sale activity, and introduced post-grant review (PGR) and inter partes review (IPR) as administrative patent validity challenges before the Patent Trial and Appeal Board (PTAB). In 2025, the USPTO proposed major new IPR rules under a Notice of Proposed Rulemaking (NPRM) issued October 16, 2025, restricting serial/parallel petitions and requiring mandatory stipulations against pursuing §§ 102/103 invalidity arguments in parallel forums.

Trademark protection operates under the Lanham Act (15 USC § 1051 et seq.), with the USPTO implementing significant fee increases effective January 18, 2025 — base application fees now at $350 per class for national direct filings, with $200 surcharges for free-form goods/services descriptions not using pre-approved identifications from the USPTO ID Manual. International trademark protection through the Madrid Protocol requires precise alignment between base and international applications, with Nice Classification (currently 12th Edition, 45 classes) governing goods/services categorization across 130+ member countries. Section 8 declarations of use (due between 5th-6th year post-registration, then every 10 years) and Section 9 renewal applications (every 10 years) are absolute deadlines — failure results in registration cancellation with no automatic reinstatement.

Trade secret protection gained federal standing through the Defend Trade Secrets Act (DTSA) of 2016, codified within the Economic Espionage Act at 18 USC §§ 1831-1839. The DTSA provides civil remedies for misappropriation alongside state Uniform Trade Secrets Act (UTSA) claims, but demands that owners demonstrate "reasonable measures" to maintain secrecy — a fact-intensive standard with no bright-line rule. The Seventh Circuit's 2024 decision in Motorola v. Hytera (108 F.4th) confirmed DTSA extraterritorial application where an act in furtherance of misappropriation occurs in the United States, producing a $135.8 million compensatory and $271.6 million punitive damages award based on worldwide sales. The DTSA also contains whistleblower immunity provisions (18 USC § 1833(b)) protecting disclosures made in confidence to government officials or filed under seal in litigation.

Enterprise IP management requires integration across legal, R&D, finance, and business strategy functions. The Bayh-Dole Act (35 USC §§ 200-212) governs inventions arising from federally funded research, requiring timely disclosure, election of title, and compliance with reporting obligations. In August 2025, the Department of Commerce took the unprecedented step of initiating march-in rights proceedings against Harvard University under 35 USC § 203, signaling heightened enforcement of Bayh-Dole compliance obligations that organizations receiving federal research funding cannot ignore.

Core Decision Framework

Patent Prosecution Decision Tree

Stage 1 — Invention Disclosure Triage: Evaluate each disclosure against three filters: (a) patentable subject matter under 35 USC § 101 (accounting for Alice/Mayo framework for abstract ideas and laws of nature), (b) strategic alignment with product roadmap or defensive objectives, and (c) prior art landscape assessment using patent search databases. Score each disclosure on a 1-5 scale across novelty, commercial value, enforceability, and design-around difficulty.

Stage 2 — Filing Strategy: Decide between provisional application (12-month priority window, lower cost, no examination) and non-provisional application (triggers examination, 20-year term from earliest effective filing date). For international protection, evaluate PCT (Patent Cooperation Treaty) filing within 12 months of priority date versus direct national filings. PCT provides 30/31-month national phase entry deadline. Consider continuation, continuation-in-part (CIP), and divisional strategies — noting that the USPTO now imposes a $2,700 surcharge for continuing applications filed 6+ years after earliest claimed benefit date, and $4,000 for 9+ years.